Preclinical development of plant‐based oral immune modulatory therapy for haemophilia B

Anti‐drug antibody (ADA) formation is a major complication in treatment of the X‐linked bleeding disorder haemophilia B (deficiency in coagulation factor IX, FIX). Current clinical immune tolerance protocols are often not effective due to complications such as anaphylactic reactions against FIX. Pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Srinivasan, Aparajitha, Herzog, Roland W., Khan, Imran, Sherman, Alexandra, Bertolini, Thais, Wynn, Tung, Daniell, Henry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486253/
https://www.ncbi.nlm.nih.gov/pubmed/33949086
http://dx.doi.org/10.1111/pbi.13608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486253/
https://www.ncbi.nlm.nih.gov/pubmed/33949086
http://dx.doi.org/10.1111/pbi.13608

Ejemplares similares